Skip to content
Companies

Akadeum Life Sciences

Microbubble cell separation for research and cell therapy

Raised to date

$7.8M

of $10.6M offered across 2 Form D filings

Still open
$2.8M
Investors
35
Last filed
Jul 9, 2026

About

Akadeum Life Sciences, Inc. is a biotechnology company that specializes in innovative cell separation technologies tailored for the life sciences industry. Its mission is to enhance the efficiency and scalability of vital sample preparation processes essential for research, diagnostics, and cell therapy applications.

Akadeum's BACS™ microbubble technology represents a breakthrough in efficient and gentle cell isolation, addressing significant challenges in sample preparation.

Funding

$7.2M round, first sold Apr 2025$5.6M sold$1.5M still openApr 20252026
Now
  • EquityFiled Jul 9, 2026Form D
    $2.1M/ $3.4M
  • EquityFiled Apr 25, 2025Form D
    $5.6M/ $7.2M

Product

BACS™ Microbubble Technology

Cell Isolation

The Buoyancy Activated Cell Sorting (BACS™) microbubble technology is a flotation-based platform designed to improve the efficiency of cell isolation and sample preparation. It uses specialized microbubbles that attach to target cells, allowing them to float for gentle and effective separation.

  • Facilitates efficient isolation of specific cell populations such as T cells.
  • Can be applied in nucleic acid extraction and protein isolation.
  • Enhances sample preparation processes for research and diagnostics.

Built for

Healthcare, biotechnology, and research laboratories

People on file